1.
ACG Case Rep J
; 6(11): e00249, 2019 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32309466
RESUMO
Immunotherapy agents such as cytotoxic T-lymphocyte antigen-4 and programed cell death protein-1 inhibitors show efficacy in cancer therapy but are associated with immune-related adverse events. It commonly presents as diarrhea but can cause colitis, mimicking inflammatory bowel disease. Our patient is a 78-year-old man on nivolumab therapy for metastatic lung cancer who developed new onset nausea and diarrhea. Endoscopy revealed inflammation of the upper and lower gastrointestinal tract, and histology revealed transmural colon and gastric inflammation. We present a fascinating case of severe concomitant aphthous ulcers, esophagitis, gastritis, and enterocolitis.
2.
Arch Pathol Lab Med
; 132(4): 536, 2008 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18384204